scispace - formally typeset
C

Chittalakkottu Sadasivan

Researcher at Kannur University

Publications -  73
Citations -  1371

Chittalakkottu Sadasivan is an academic researcher from Kannur University. The author has contributed to research in topics: Docking (molecular) & Acetylcholinesterase. The author has an hindex of 17, co-authored 69 publications receiving 1002 citations. Previous affiliations of Chittalakkottu Sadasivan include Indian Institute of Science.

Papers
More filters
Journal ArticleDOI

Anti‐Inflammatory Property of n‐Hexadecanoic Acid: Structural Evidence and Kinetic Assessment

TL;DR: It may be concluded from the structural and kinetics studies that the fatty acid, n‐hexadecanoic acid, is an inhibitor of phospholipase A2, hence, an anti‐inflammatory compound, validate the rigorous use of medicated oils rich in n‐ hexadecanoIC acid for the treatment of rheumatic symptoms in the traditional medical system of India, Ayurveda.
Journal ArticleDOI

Bisphenol-A can bind to human glucocorticoid receptor as an agonist: an in silico study

TL;DR: It is found that the mode of interactions and binding energy of BPA were similar to that of DEXA and cortisol, two known agonists of GR, which reveals that BPA can bind to GR as an agonist and may produce biological effectssimilar to that produced by glucocorticoids.
Journal ArticleDOI

Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening, molecular docking and molecular dynamics with main protease as the target.

TL;DR: Results showed that the drugs Binifibrate and Bamifylline bind strongly to the enzyme active site and hence they can be repurposed against SARS-CoV-2, however, U.S Food and Drug Administration have withdrawn BinIFibrate from the market as it was having some adverse health effects on patients.
Journal ArticleDOI

Cellular calcium signaling in the aging brain.

TL;DR: This review attempts to summarize changes in calcium signaling in the brain as a result of aging.
Journal ArticleDOI

Novel tacrine derivatives exhibiting improved acetylcholinesterase inhibition: Design, synthesis and biological evaluation

TL;DR: It can be suggested that the compound 4c might be a potential drug lead compound with AChE inhibitory activity, however, further pharmacokinetic studies are necessary to comment on the efficacy of the compound as a drug for AD.